STAT6 and IL-4 receptor (IL4R) expression in human HCC TAMs, along with the identification of a STAT6-related transcriptional signature associated with poor prognosis in HCC and other cancers, supports the rationale for clinical development [116]. Here, STAT6 is linked to hepatocellular carcinoma.